About Salignostics

Salignostics develops saliva-based rapid diagnostic tests that utilize saliva concentrator technology to amplify biomarkers and standardize sample volumes for accurate detection. This approach eliminates the need for invasive blood samples, reducing costs and improving accessibility for healthcare providers and home-testing markets.

```xml <problem> Traditional diagnostic methods often rely on invasive blood, serum, and urine samples, which can be costly, slow, and require professional handling, creating barriers to fast and accessible healthcare. Furthermore, these methods are not ideal for self-testing or point-of-care settings. </problem> <solution> Salignostics provides a platform for rapid diagnostic testing using saliva, offering a non-invasive and accessible alternative to traditional methods. Their technology overcomes the challenges of saliva-based testing by amplifying biomarkers, neutralizing inhibitory agents, and standardizing sample volumes, ensuring reliable and accurate results. The platform supports lateral flow immunoassays for the detection of various biomarkers, including human proteins, viral proteins, DNA, and RNA. This approach enables faster, safer, and more cost-effective diagnostics in home, point-of-care, and laboratory settings, reducing the burden on healthcare professionals and expanding access to a broader population. </solution> <features> - Saliva concentrator technology to amplify low biomarker concentrations for accurate detection. - Advanced unmasking capabilities to filter out inhibitory substances in saliva. - Metered collection system to standardize saliva volume for reliable testing. - Rapid results in minutes, improving the efficiency of healthcare operations. - Non-invasive and painless sample collection, ideal for children and sensitive populations. - Bio-safe testing minimizes the risk of contamination. - Versatile platform applicable to a wide range of biomarkers, including proteins, DNA, and RNA. - CE-approved saliva-based pregnancy test (Salistick™) available in retail stores. </features> <target_audience> Salignostics targets global healthcare providers, home-testing markets, and laboratories seeking accessible, rapid, and reliable diagnostic solutions. </target_audience> ```

What does Salignostics do?

Where is Salignostics located?

Salignostics is based in Jerusalem, Israel.

When was Salignostics founded?

Salignostics was founded in 2016.

How much funding has Salignostics raised?

Salignostics has raised 16000000.

Location

Jerusalem, Israel

Founded

2016

Funding

16000000

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Salignostics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

salignostics.com LinkedIn Profile

Founded 2016 – Jerusalem, Israel

Funding

Estimated Funding

$10M+

Team

No team information available.

Company Description

Problem

Traditional diagnostic methods often rely on invasive blood, serum, and urine samples, which can be costly, slow, and require professional handling, creating barriers to fast and accessible healthcare. Furthermore, these methods are not ideal for self-testing or point-of-care settings.

Solution

Salignostics provides a platform for rapid diagnostic testing using saliva, offering a non-invasive and accessible alternative to traditional methods. Their technology overcomes the challenges of saliva-based testing by amplifying biomarkers, neutralizing inhibitory agents, and standardizing sample volumes, ensuring reliable and accurate results. The platform supports lateral flow immunoassays for the detection of various biomarkers, including human proteins, viral proteins, DNA, and RNA. This approach enables faster, safer, and more cost-effective diagnostics in home, point-of-care, and laboratory settings, reducing the burden on healthcare professionals and expanding access to a broader population.

Features

Saliva concentrator technology to amplify low biomarker concentrations for accurate detection.

Advanced unmasking capabilities to filter out inhibitory substances in saliva.

Metered collection system to standardize saliva volume for reliable testing.

Rapid results in minutes, improving the efficiency of healthcare operations.

Non-invasive and painless sample collection, ideal for children and sensitive populations.

Bio-safe testing minimizes the risk of contamination.

Versatile platform applicable to a wide range of biomarkers, including proteins, DNA, and RNA.

CE-approved saliva-based pregnancy test (Salistick™) available in retail stores.

Target Audience

Salignostics targets global healthcare providers, home-testing markets, and laboratories seeking accessible, rapid, and reliable diagnostic solutions.